Seeking Alpha

Depomed (DEPO) says that its lawsuits against two filers of Abbreviated New Drug Applications...

Depomed (DEPO) says that its lawsuits against two filers of Abbreviated New Drug Applications for Gralise have been dismissed at its own request. The dismissal was requested after Watson Laboratories (WPI) withdrew its application, and Par Pharmaceutical (PRX) amended its to no longer seek approval prior to the expiration of DEPO's Gralise patents listed for in the FDA's Orange Book.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs